PROJECT PORTFOLIO AND COLLABORATION

ADS:NAE — N-stearoylethanolamine molecule over a tea field

ADS:NAE

Healthy Ageing & Metabolic Longevity

Production of rapidly dissolving sublingual tablets (ODT matrices) based on the natural metabolite N-stearoylethanolamine.

ADS:AMI — bedroom scene representing sleep systems

ADS:AMI

Mental Health & Sleep Systems

Production of fast-dissolving sublingual tablets (ODT matrices) based on a GABA-mimetic isoxazole to normalize sleep homeostasis.

ADS:NAS — laboratory glassware with a leaf and molecular structure

ADS:NAS

Metabolic & Mental Balance

Modification of native D-camphoric acid raw material to bring the substance into industrial production as ODT formulations.

ADS:DAG — runner with a molecular structure overlay

ADS:DAG

Energy & Endurance Boost

Development of a buffered polymer matrix of deanol succinate to bring the substance into industrial production as finished ODT formulations.

GREEN-SEED TECHNOLOGY - AGROTECH INNOVATION

Industrial-scale production of a multifunctional nanocomposite to replace toxic chemical seed treatments (for planting material) and bring this agricultural technology to market.

ASPEGON INVITES INSTITUTIONAL INVESTORS

Venture capital funds, and specialized B2B partners to collaborate. We offer investments in a high-tech BioTech & Agrotech portfolio.

OUR COLLABORATION FORMATS

Target Funding

Project financing using the Stage-Gate system with minimal risks.

Co-Development & Scale-up

Joint scaling of R&D protocols to industrial production.

IP Licensing

Licensing of ready-to-use technical processes and modified molecules.